Lassègue, B <br/><br/>
Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.  [electronic resource] 

 -  Molecular pharmacology  Oct 1995 
 - 601-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0026-895X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--metabolism<br/>Angiotensin II--pharmacology<br/>Angiotensin Receptor Antagonists<br/>Animals<br/>Autoradiography<br/>Base Sequence<br/>Biphenyl Compounds--pharmacology<br/>Calcium--metabolism<br/>Cyclic AMP--metabolism<br/>Cytoplasm--metabolism<br/>Dactinomycin--pharmacology<br/>Down-Regulation--drug effects<br/>Enzyme Activation--drug effects<br/>Imidazoles--pharmacology<br/>Losartan<br/>Molecular Sequence Data<br/>Muscle Proteins--metabolism<br/>Muscle, Smooth, Vascular--metabolism<br/>Protein Kinase C--antagonists & inhibitors<br/>Protein Processing, Post-Translational--drug effects<br/>Protein Synthesis Inhibitors--pharmacology<br/>Purinergic P1 Receptor Agonists<br/>Purinergic P2 Receptor Agonists<br/>RNA, Messenger--genetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Angiotensin--genetics<br/>Receptors, Purinergic P1--physiology<br/>Receptors, Purinergic P2--physiology<br/>Signal Transduction--drug effects<br/>Tetrazoles--pharmacology<br/>Transcription, Genetic--drug effects